<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Cherilakkudy FH</submitter><funding>NIGMS NIH HHS</funding><pagination>102779</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12439684</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>6(8)</volume><pubmed_abstract>ALKBH5 is one of only two known human non-heme Fe(II)/2-oxoglutarate-dependent oxygenases that catalyze the demethylation of N&lt;sup>6&lt;/sup>-methyladenine (m&lt;sup>6&lt;/sup>A) in single-stranded mRNA, underscoring its role in diverse cancers. Unlike its homolog, the fat mass and obesity-associated protein (FTO), which oxidizes m&lt;sup>6&lt;/sup>A to a stable N&lt;sup>6&lt;/sup>-hydroxymethyladenine (hm&lt;sup>6&lt;/sup>A) intermediate, ALKBH5 demethylates m&lt;sup>6&lt;/sup>A, yielding adenine and formaldehyde as products. Here, we integrate molecular dynamics simulations and quantum mechanics/molecular mechanics methods to elucidate ALKBH5's complete catalytic mechanism. Two post-hydroxylation pathways were evaluated: a proton transfer pathway and a Schiff base formation pathway, with the former emerging as the favor</pubmed_abstract><journal>Cell reports. Physical science</journal><pubmed_title>Revealing the catalytic mechanism of the Fe(II)/2-oxoglutarate-dependent human epigenetic modifying enzyme ALKBH5.</pubmed_title><pmcid>PMC12439684</pmcid><funding_grant_id>R35 GM156437</funding_grant_id><pubmed_authors>Waheed SO</pubmed_authors><pubmed_authors>Li D</pubmed_authors><pubmed_authors>Christov CZ</pubmed_authors><pubmed_authors>Cherilakkudy FH</pubmed_authors><pubmed_authors>Thomas MG</pubmed_authors><pubmed_authors>Venditti V</pubmed_authors><pubmed_authors>Karabencheva-Christova TG</pubmed_authors><pubmed_authors>Krishnan A</pubmed_authors><pubmed_authors>Varghese A</pubmed_authors><pubmed_authors>Schofield CJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Revealing the catalytic mechanism of the Fe(II)/2-oxoglutarate-dependent human epigenetic modifying enzyme ALKBH5.</name><description>ALKBH5 is one of only two known human non-heme Fe(II)/2-oxoglutarate-dependent oxygenases that catalyze the demethylation of N&lt;sup>6&lt;/sup>-methyladenine (m&lt;sup>6&lt;/sup>A) in single-stranded mRNA, underscoring its role in diverse cancers. Unlike its homolog, the fat mass and obesity-associated protein (FTO), which oxidizes m&lt;sup>6&lt;/sup>A to a stable N&lt;sup>6&lt;/sup>-hydroxymethyladenine (hm&lt;sup>6&lt;/sup>A) intermediate, ALKBH5 demethylates m&lt;sup>6&lt;/sup>A, yielding adenine and formaldehyde as products. Here, we integrate molecular dynamics simulations and quantum mechanics/molecular mechanics methods to elucidate ALKBH5's complete catalytic mechanism. Two post-hydroxylation pathways were evaluated: a proton transfer pathway and a Schiff base formation pathway, with the former emerging as the favor</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Aug</publication><modification>2026-06-01T06:21:59.503Z</modification><creation>2026-04-08T09:46:29.097Z</creation></dates><accession>S-EPMC12439684</accession><cross_references><pubmed>40963693</pubmed><doi>10.1016/j.xcrp.2025.102779</doi></cross_references></HashMap>